Cytokinetics Inc (CYTK)
Payables turnover
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Cost of revenue | US$ in thousands | 173,612 | 177,977 | 99,603 | 52,820 | 39,610 |
| Payables | US$ in thousands | 21,507 | 25,611 | 21,087 | 8,050 | 8,160 |
| Payables turnover | 8.07 | 6.95 | 4.72 | 6.56 | 4.85 |
December 31, 2023 calculation
Payables turnover = Cost of revenue ÷ Payables
= $173,612K ÷ $21,507K
= 8.07
The payables turnover ratio for Cytokinetics Inc has been consistently reported as 0.00 for the past five years, indicating that the company is not effectively managing its accounts payable. A lower payables turnover ratio suggests that the company is taking longer to pay its suppliers, which may negatively impact its relationships with vendors. This could also potentially indicate liquidity issues or inefficiencies in the company's accounts payable process. Further investigation and improvement in managing payables may be necessary to optimize working capital management and enhance overall operational efficiency.
Peer comparison
Dec 31, 2023